Question 1

What is the catalog number for Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg)?

Accepted Answer

The catalog number for Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) is 801118.

Question 2

Is Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) in stock?

Accepted Answer

Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

Who manufactures Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg)?

Accepted Answer

Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) is manufactured by ZPTX.

Question 4

What is the estimated delivery time for Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg)?

Accepted Answer

Estimated delivery time for Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg) is approximately 10 business day(s), depending on your location.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Anti-HTLV Type I gp46 Clone 68/4.11.21 (1 mg)

Product Specifications

Frequently Asked Questions

Explore Other Products

Ep-CAM / CD326 (EGP40/826), 1mg/mL

Spermidine or Spermine N1-Acetyltransferase 1 (CPTC-SAT1-3), CF640R conjugate, 0.1mg/mL

Mitochondrial Marker (MTC754), CF640R conjugate, 0.1mg/mL

Spectrin beta III (SPTBN2) (SPTBN2/1778), CF405S conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), 0.2mg/mL

FAT1 (FAT atypical cadherin 1) (FAT1-3D7/1), 1mg/mL